Page last updated: 2024-09-05

2-anilino-5-thiazolinone and Kahler Disease

2-anilino-5-thiazolinone has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doi, N; Du, W; Genma, H; Hattori, Y; Hirano, T; Iijima, S; Kimura, H; Naito, Y; Ono, T; Shiheido, H; Takashima, H; Tokunaga, M; Yamada, T; Yanagawa, H	1

Other Studies

1 other study(ies) available for 2-anilino-5-thiazolinone and Kahler Disease

Article	Year
An anilinoquinazoline derivative inhibits tumor growth through interaction with hCAP-G2, a subunit of condensin II. PloS one, 2012, Volume: 7, Issue:9 Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromosome Segregation; DNA-Binding Proteins; Drug Resistance, Neoplasm; Humans; Male; Mice; Mitosis; Multiple Myeloma; Multiprotein Complexes; Protein Binding; Protein Subunits; Risk; Thiazoles; Xenograft Model Antitumor Assays	2012

Article

Year

An anilinoquinazoline derivative inhibits tumor growth through interaction with hCAP-G2, a subunit of condensin II.

PloS one, 2012, Volume: 7, Issue:9

Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromosome Segregation; DNA-Binding Proteins; Drug Resistance, Neoplasm; Humans; Male; Mice; Mitosis; Multiple Myeloma; Multiprotein Complexes; Protein Binding; Protein Subunits; Risk; Thiazoles; Xenograft Model Antitumor Assays

2012